George Pogson
Cardiovascular Disease · Independence, MONPI 1851396055
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $793 and has fallen 88.3% since, to $92 in 2021. That places this record below the midpoint for cardiovascular disease clinicians in MO, where the typical reported total is $1,720.
Across 84 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$242
- Amgen$171
- Boston Scientific$160
- E.r. Squibb & Sons, L.L.C.$84
- AstraZeneca$82
- Novartis$73
- plus $460 from 13 others
What the payments were for
- Food & beverage$1,272100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $242 |
| Amgen | 13 | $171 |
| Boston Scientific | 11 | $160 |
| E.r. Squibb & Sons, L.L.C. | 7 | $84 |
| AstraZeneca | 5 | $82 |
| Novartis | 5 | $73 |
| Sanofi-aventis U.S. LLC | 5 | $72 |
| Amarin Pharma, Inc. | 4 | $67 |
| Pfizer | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $40 |
| Boehringer Ingelheim | 2 | $37 |
| Lundbeck LLC | 2 | $25 |
| Aegerion Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Infobionic, Inc | 1 | $17 |
| Medtronic | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$1,272 in reported general payments places this provider in the 45th percentile of 391 cardiovascular disease providers in Missouri.
Other cardiovascular disease in Independence
- Stephen DicksonIndependence$98K
- Thao DuongIndependence$27K
- Mikhail KosiborodKansas City$1.1M
- Georges ChahoudSaint Louis$937K
- William BowenSaint Louis$726K
- Daniel KellySaint Louis$582K
- John SpertusKansas City$360K
- James FairlambColumbia$342K
- James EllisonChesterfield$267K
- Osler Jay GuzonSaint Louis$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.